Global Metastatic Melanoma Therapeutics Market
Melanoma is a disease in which malignant (cancer) cells form in melanocytes (cells that color the skin). Metastatic melanoma is melanoma that has spread to other parts of the body. It can spread to the subcutaneous tissue which lies underneath the lymph nodes, the skin, and to other organs, such as the brain, bone, liver, or lungs. Although in many cases metastatic melanoma cannot be cured, treatments and support can help people live longer and better. Treatment may include radiation therapy, chemotherapy, medication, or in some cases, surgery. However, the treatment becomes much more difficult as it spreads to other parts of the body.
The global metastatic melanoma therapeutics market is estimated to be US$ 6,432.3 million in 2021 and is expected to reach US$ 13,828.9 million by 2028, at a CAGR of 11.6% during the forecast period (2021 –2028).
𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @
Key Market Drivers:
Rising incidence of melanoma and other skin cancers across the globe is expected to propel growth of the metastatic melanoma therapeutics market over the forecast period. For instance, according to the World Health Organization (WHO), the incidence of both non-melanoma and melanoma skin cancers has been increasing over the past decades. Each year, between 2 and 3 million non-melanoma skin cancers and 132,000 melanoma skin cancers occur worldwide.
Moreover, increasing number of clinical trials and increasing research and development is expected to augment the growth of the metastatic melanoma therapeutics market. For instance, in January 2022, Evaxion Biotech received clearance from the Australia Therapeutic Goods Administration to initiate a Phase 2b trial of its patient specific cancer immunotherapy EVX-01 in combination with Merck’s KEYTRUDA (pembrolizumab) to treat melanoma.
COVID-19 Impact Analysis:
The outbreak of COVID-19 has severely affected the production, development, and supply of pharmaceutical products, as well as growth of the metastatic melanoma therapeutics market. The pandemic has affected the economy in several ways; such as by affecting both production and demand and creating supply chain disruptions. Moreover, elective operations were reduced significantly to eliminate the risk of infection for both medical personnel and patients and to leave the clinical facilities and intensive care available for access to COVID-19 patients.
Buy This Complete Business Report With Flat 30% Off @
The metastatic melanoma therapeutics market is expected to exhibit a CAGR of 11.6% during the forecast period owing to the frequent approvals and launches of novel products. For instance, in September 2021, the Food and Drug Administration (FDA) granted a fast track designation to the novel MDM2-p53 inhibitor alrizomadlin (APG-115) to treat people with unresectable or metastatic melanoma.
Among regions, North America, Europe, and Asia Pacific are expected to witness robust growth in the metastatic melanoma therapeutics market owing to the increasing burden of melanoma cases, growing demand for metastatic melanoma treatment, rising governments initiatives for skin cancer treatment, and development of new biologics in these regions. The rates of melanoma have been rising rapidly over the past few decades. For instance, according to the American Cancer Society, in 2022, around 99,780 new cases of melanoma will be diagnosed in the United States and 7,650 people will die from the disease.
Major players operating in the global metastatic melanoma therapeutics market are Vical, Inc., Pfizer, Inc., GlaxoSmithKline, Eisai Co., Ltd, AgonOX, Inc., AB Sciences, AstraZeneca, F. Hoffmann-La Roche AG., Genentech Inc., Amgen Inc., Merck & Co., Inc., Novartis, Bristol-Myers Squibb Company, and Daiichi Sankyo Company Ltd., among others.
Global Metastatic melanoma therapeutics Market, By Therapy:
- Targeted Therapy
- Radiation Therapy
Global Metastatic melanoma therapeutics Market, By Stages:
- Stage 0
- Stage I
- Stage II
- Stage III
- Stage IV
Global Metastatic melanoma therapeutics Market, By End User:
- Specialty Clinics
- Home Healthcare
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Metastatic Melanoma Therapeutics Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Metastatic Melanoma Therapeutics Industry Impact
Chapter 2 Global Metastatic Melanoma Therapeutics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Metastatic Melanoma Therapeutics (Volume and Value) by Type
2.3 Global Metastatic Melanoma Therapeutics (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Metastatic Melanoma Therapeutics Sales, Consumption, Export, Import by Regions
Chapter 5 North America Metastatic Melanoma Therapeutics Market Analysis
Chapter 6 East Asia Metastatic Melanoma Therapeutics Market Analysis
Chapter 7 Europe Metastatic Melanoma Therapeutics Market Analysis
Chapter 8 South Asia Metastatic Melanoma Therapeutics Market Analysis
Chapter 9 Southeast Asia Metastatic Melanoma Therapeutics Market Analysis
Chapter 10 Middle East Metastatic Melanoma Therapeutics Market Analysis
Chapter 11 Africa Metastatic Melanoma Therapeutics Market Analysis
Chapter 12 Oceania Metastatic Melanoma Therapeutics Market Analysis
Chapter 13 South America Metastatic Melanoma Therapeutics Market Analysis
Chapter 14 Company Profiles and Key Figures in Metastatic Melanoma Therapeutics Business
Chapter 15 Global Metastatic Melanoma Therapeutics Market Forecast (2021-2028)
Chapter 16 Conclusions
Request PDF Brochure with Latest Insights @
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027